Genomictree Inc. (KOSDAQ:228760)
 21,200
 +1,530 (7.78%)
  Oct 31, 2025, 1:40 PM KST
Genomictree Market Cap
Genomictree has a market cap or net worth of 472.41 billion as of October 30, 2025. Its market cap has increased by 29.60% in one year.
Market Cap 
 472.41B
Enterprise Value 
 388.60B
Revenue 
 3.56B
Ranking 
 n/a
PE Ratio 
 n/a
Stock Price 
21,200.00
Market Cap Chart
Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 472.41B, an increase of 700.72%. That is a compound annual growth rate of 27.46%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 472.41B | -3.71% | 
| Dec 30, 2024 | 490.60B | 0.78% | 
| Dec 28, 2023 | 486.82B | 168.25% | 
| Dec 29, 2022 | 181.48B | -32.87% | 
| Dec 30, 2021 | 270.36B | -7.66% | 
| Dec 30, 2020 | 292.80B | -37.53% | 
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro | 
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Samsung Biologics | 87.69T | 
| Celltrion | 39.50T | 
| ALTEOGEN | 25.46T | 
| SK Biopharmaceuticals | 9.08T | 
| Yuhan | 8.94T | 
| HLB Co., Ltd. | 6.25T | 
| Peptron | 6.06T | 
| PharmaResearch | 5.57T |